EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access

Incidence of Chronic Thromboembolic Pulmonary Hypertension After Pulmonary Embolism in the Era of Direct Oral Anticoagulants: From the COMMAND VTE Registry‐2

Nobutaka Ikeda iD, Yugo Yamashita iD, Takeshi Morimoto iD, Ryuki Chatani iD, Kazuhisa Kaneda iD, Yuji Nishimoto iD, Yohei Kobayashi, Satoshi Ikeda iD, Kitae Kim, Moriaki Inoko iD, Toru Takase, Shuhei Tsuji iD und 22 weitere

Journal of the American Heart Association · 05.11.2024 · 13 (21)

DOI: 10.1161/jaha.124.035997 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of the American Heart Association, erschienen am 05.11.2024. Verfasst von Nobutaka Ikeda und 33 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiovascular Medicine Toho University Medical Center Ohashi Hospital Tokyo Japan. Hauptthemen laut MEDLINE: Pulmonary Embolism, Registries, Hypertension, Pulmonary. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Chronic thromboembolic pulmonary hypertension (CTEPH) is a life‐threatening complication post‐acute pulmonary embolism (PE). The assessment of CTEPH incidence and risk factors post‐acute PE in the era of direct oral anticoagulants remains insufficient. Methods and Results The COMMAND VTE Registry‐2 (contemporary management and outcomes in patients with venous thromboembolism registry‐2) is a multicenter registry that recruited consecutive patients with acute symptomatic venous thromboembolism from 31 centers across Japan. The primary outcome was to demonstrate the detection rate of CTEPH after acute PE in routine clinical practice. Out of the 5197 patients with venous thromboembolism included in the COMMAND VTE Registry‐2, 2787 were diagnosed with acute PE. Following a median follow‐up duration of 747 days, 48 cases of CTEPH were detected, and the cumulative diagnosis of CTEPH in routine clinical practice was 2.3% at 3 years. Independent risk factors for the detection of CTEPH by multivariable Cox regression analysis included women (hazard ratio [HR] 2.09 [95% CI, 1.05–4.14]), longer interval from symptom onset to diagnosis of PE (each 1 day, HR 1.04 [95% CI, 1.01–1.07]), hypoxemia at diagnosis (HR 2.52 [95% CI, 1.26–5.04]), right heart load (HR 9.28 [95% CI, 3.19–27.00]), lower D‐dimer value (each 1 μg/mL, HR 0.96 [95% CI, 0.92–0.99]), and unprovoked PE (HR 2.77 [95% CI, 1.22–6.30]).

Conclusions

In the direct oral anticoagulant era, the cumulative diagnosis of CTEPH after acute PE was 2.3% at 3 years, and several independent risk factors for CTEPH were identified, which could be useful for screening a high‐risk population after acute PE.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pulmonary EmbolismRegistriesHypertension, PulmonaryHumansFemaleMaleIncidenceAgedMiddle AgedJapanRisk FactorsChronic DiseaseAnticoagulantsAdministration, OralRisk AssessmentTime Factors

Stichwörter der Autor:innen

acute pulmonary embolismchronic thromboembolic pulmonary hypertensiondirect oral anticoagulants

Substanzen

Anticoagulants

Autor:innen und Institutionen

  • Division of Cardiovascular Medicine Toho University Medical Center Ohashi Hospital Tokyo Japan.
  • Department of Cardiovascular Medicine, Graduate School of Medicine Kyoto University Kyoto Japan.
  • Department of Clinical Epidemiology Hyogo College of Medicine Nishinomiya Japan.
  • Department of Cardiovascular Medicine Kurashiki Central Hospital Kurashiki Japan.
  • Department of Cardiology Hyogo Prefectural Amagasaki General Medical Center Amagasaki Japan.
  • Department of Cardiovascular Center Osaka Red Cross Hospital Osaka Japan.

ORCID-Profile: Nobutaka Ikeda, Yugo Yamashita, Takeshi Morimoto, Ryuki Chatani, Kazuhisa Kaneda, Yuji Nishimoto, Satoshi Ikeda, Moriaki Inoko, Shuhei Tsuji, Maki Oi, Takuma Takada, Yoshito Ogihara, Takeshi Inoue, Shunsuke Usami, Kiyonori Togi, Norimichi Koitabashi, Seiichi Hiramori, Hiroshi Mabuchi, Yoshiaki Tsuyuki, Koichiro Murata, Kensuke Takabayashi, Hisato Nakai, Daisuke Sueta, Wataru Shioyama, Takeshi Kimura

Zitieren

APA

Ikeda, N., Yamashita, Y., Morimoto, T., Chatani, R., Kaneda, K., Nishimoto, Y., Kobayashi, Y., Ikeda, S., Kim, K., Inoko, M., Takase, T., Tsuji, S., Oi, M., Takada, T., Otsui, K., Sakamoto, J., Ogihara, Y., Inoue, T., Usami, S., …, & COMMAND VTE Registry‐2 Investigators (2024). Incidence of Chronic Thromboembolic Pulmonary Hypertension After Pulmonary Embolism in the Era of Direct Oral Anticoagulants: From the COMMAND VTE Registry‐2. Journal of the American Heart Association, 13(21). https://doi.org/10.1161/jaha.124.035997

Vancouver

Ikeda N, Yamashita Y, Morimoto T, Chatani R, Kaneda K, Nishimoto Y, et al. Incidence of Chronic Thromboembolic Pulmonary Hypertension After Pulmonary Embolism in the Era of Direct Oral Anticoagulants: From the COMMAND VTE Registry‐2. Journal of the American Heart Association. 2024;13(21). doi:10.1161/jaha.124.035997

BibTeX
@article{Ikeda2024,
  author = {Ikeda, Nobutaka and Yamashita, Yugo and Morimoto, Takeshi and Chatani, Ryuki and Kaneda, Kazuhisa and Nishimoto, Yuji and Kobayashi, Yohei and Ikeda, Satoshi and Kim, Kitae and Inoko, Moriaki and Takase, Toru and Tsuji, Shuhei and Oi, Maki and Takada, Takuma and Otsui, Kazunori and Sakamoto, Jiro and Ogihara, Yoshito and Inoue, Takeshi and Usami, Shunsuke and Chen, Po-Min and Togi, Kiyonori and Koitabashi, Norimichi and Hiramori, Seiichi and Doi, Kosuke and Mabuchi, Hiroshi and Tsuyuki, Yoshiaki and Murata, Koichiro and Takabayashi, Kensuke and Nakai, Hisato and Sueta, Daisuke and Shioyama, Wataru and Dohke, Tomohiro and Kimura, Takeshi and COMMAND VTE Registry‐2 Investigators, COMMAND VTE Registry‐2 Investigators},
  title = {Incidence of Chronic Thromboembolic Pulmonary Hypertension After Pulmonary Embolism in the Era of Direct Oral Anticoagulants: From the COMMAND VTE Registry‐2},
  journal = {Journal of the American Heart Association},
  year = {2024},
  volume = {13},
  number = {21},
  doi = {10.1161/jaha.124.035997}
}
Kostenlos starten →